Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aciclovir/hydrocortisone cream - Medivir

Drug Profile

Aciclovir/hydrocortisone cream - Medivir

Alternative Names: Acyclovir/hydrocortisone; Lipsovir®; ME-609; Xerclear; Xerese

Latest Information Update: 13 Feb 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AstraZeneca; Medivir AB
  • Developer Bausch Health Companies; Daewoong Pharmaceutical; Meda; Medivir AB
  • Class Anti-inflammatories; Antiallergics; Antivirals; Glucocorticoids; Hypoxanthines; Nucleosides; Pregnenediones; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors; Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Herpes labialis

Most Recent Events

  • 13 Feb 2019 Chemical structure information added
  • 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
  • 05 Aug 2016 Meda has been acquired by Mylan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top